Skip to content

Author

Thomas F. Meyer

We have 2 of 31 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

EARLY-ALS: a multicentre study on prodromal amyotrophic lateral sclerosis.

BACKGROUND Neurodegenerative diseases often feature a prolonged phase of subtle changes preceding diagnosis. In amyotrophic lateral sclerosis (ALS), defining this prodromal period is critical for identifying early disease features and intervention windows. METHODS In this case-control study, 475 patients with ALS and...

I. Cordts, A. Galhoz, L. Tzeplaeff et al. · 0 citations
Open access Jul 2026

Multiplex Panel Detects Glial and Inflammatory Biomarker Signatures in Sporadic and C9orf72-ALS

The NULISA multiplex platform supports the use of a multiplexed panel of diverse, inflammatory, glial, and neurodegeneration-associated biomarkers as a complementary diagnostic and prognostic tool alongside established measurements of neurofilaments.

Karthik Baskar, Christina Steffke, S. Bernsen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.